Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: Association with clinicopathological parameters

Anticancer Research

Volumn 25, Issue 6 C, 2005, Pages 4699-4706

  Raju, Bina ^a   Mehrotra, Ravi ^b   Øijordsbakken, Gunnvor ^c   Al Sharabi, Ali K ^d   Vasstrand, Endre N ^a   Ibrahim, Salah O ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF ALLAHABAD   (India)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d SANA A UNIVERSITY   (Yemen)

Author keywords

Cyclin D1; India; Oral cancer; p53; qat; Yemen

Indexed keywords

BIOLOGICAL MARKER; CYCLIN D1; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INDIA; MALE; MOUTH CANCER; MOUTH MUCOSA; POPULATION EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; SMOKING HABIT; STATISTICAL SIGNIFICANCE; TISSUE FIXATION; YEMEN;

ADULT; AGED; CYCLIN D1; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 28444441886     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Franceschi S, Bidoli E, Herrero R and Munoz N: Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol 36B: 106-115, 2000.
2. Llewellyn CD and Johnson NW: Risk factors for squamous cell carcinoma of the oral cavity in young people-a comprehensive literature review. Oral Oncol 37B: 401-418, 2001.
3. Castellsague X, Quintana MJ, Martinez MC et al: The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer 108: 741-749, 2004.
4. Pindborg JJ, Reichart PA, Smith CJ and Van der Waal I: Histological Typing of Cancer and Precancer of the Oral Mucosa, Second edition, Berlin: Springer-Verlag, 1997.
5. Kannan S, Balaram P, Pillai MR et al: Ultrastructural variations and assessment of malignant transformation risk in oral leukoplakia. Pathol Res Pract 189: 1169-1180, 1993.
6. Gupta PC, Bhonsle RB, Murti PR, Daftary DK, Mehta FS and Pindborg JJ: An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer 63: 2247-2252, 1989.
7. Al-Thobhani AK, Raja'a YA and Noman TA: The pattern and distribution of malignant neoplasms among Yemeni patients. Saudi Med J 22: 910-913, 2001.
8. Dhaifalah I and Santavy J: Khat habit and its health effect. A natural amphetamine. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 148: 11-15, 2004.
9. Hill CM and Gibson A: The oral and dental effects of qat chewing. Oral Surg Oral Med Oral Pathol 63: 433-436, 1987.
10. Ali AA, Al-Sharabi AK, Aguirre JM and Nahas R: A study of 342 oral keratotic white lesions induced by qat chewing among 2500 Yemeni. J Oral Pathol Med 33: 368-372, 2004.
11. Nasr AH and Khatri ML: Head and neck squamous cell carcinoma in Hajjah, Yemen. Saudi Med J 21: 565-568, 2000.
12. Mehrotra R, Singh M, Kumar D, Pandey AN, Gupta RK and Sinha US: Age specific incidence rate and pathological spectrum of oral cancer in Allahabad. Indian J Med Sci 57: 400-404, 2003.
13. Topping G: Smokeless tobacco use is associated with a substantial risk of oral cancers in India. Evid Based Dent 5: 79, 2004.
14. Sherr CJ: D-type cyclins. Trends Biochem Sci 20: 187-190, 1995.
15. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
16. Endl E and Gerdes J: The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 257: 231-237, 2000.
17. Kovesi G and Szende B: Changes in apoptosis and mitotic index, p53 and Ki67 expression in various types of oral leukoplakia. Oncology 65: 331-336, 2003.
18. Schoelch ML, Regezi JA, Dekker NP et al: Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol 35: 333-342, 1999.
19. Regezi JA and Jordan RC: Oral cancer in the molecular age. J Calif Dent Assoc 29: 578-584, 2001.
20. Katiyar S, Thelma BK, Murthy NS et al: Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem 252: 117-124, 2003.
21. Tandle AT, Sanghvi V and Saranath D: Determination of p53 genotypes in oral cancer patients from India. Br J Cancer 84: 739-742, 2001.
22. Whyte DA and Broton CE: The unexplained survival of cells in oral cancer: what is the role of p53? J Oral Pathol Med 31: 25-133, 2002.
23. Rich AM and Kerdpon D: p53 expression in oral precancer and cancer. Aust Dent J 44: 103-105, 1999.
24. Kuttan NA, Rosin MP, Ambika K, Priddy RW, Bhakthan NM and Zhang L: High prevalence of expression of p53 oncoprotein in oral carcinomas from India associated with betel and tobacco chewing. Eur J Cancer (Oral Oncol) 31B: 169-173, 1995.
25. Kaur J, Srivastava A and Ralhan R: Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India. Int J Cancer 58: 340-345, 1994.
26. Michalides RJ, van Veelen NM, Kristel PM et al: Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 723: 497-502, 1997.
27. Rousseau A, Lim MS, Lin Z and Jordan RC: Frequent cyclin D1 gene amplification and protein Overexpression in oral epithelial dysplasias. Oral Oncol 37: 268-275, 2001.
28. Lam KY, Ng IO, Yuen AP, Kwong DL and Wei W: Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression. J Oral Pathol Med 29: 167-172, 2000.
29. Liu SC and Zhang SY: Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 10: 455-459, 2001.
30. Dissanayake U, Johnson NW and Warnakulasuriya KA: Comparison of cell proliferation in the centre and advancing fronts of oral squamous cell carcinomas using Ki-67 index. Cell Prolif 36: 255-264, 2003.
31. Iamaroon A, Khemaleelakul U, Pongsiriwet S and Pintong J: Coexpression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma. J Oral Pathol Med 33: 30-36, 2004.
32. Carlos de Vicente J, Herrero-Zapatero A, Fresno MF and Lopez-Arranz JS: Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance, Oral Oncol 38: 301-308, 2002.
33. Mineta H, Borg A, Dictor M, Wahlberg P and Wennerberg J: Correlation between p53 mutation and cyclin D1 amplification in head and neck squamous cell carcinoma. Oral Oncol 33: 42-46, 1997.